JG

Jeff Goater

Partner at The Column Group

Greater Boston

Investor
VC
CEO

Invests in

Stages:

Series B
Series A
Seed

Sectors:

Consumer Health
Digital Health
Health & Hospital Services
Health IT
BioTech
Boston / New England

Locations:

Boston, Massachusetts
  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Skills

Corporate Finance
Start-ups
Corporate Development
Valuation
Mergers & Acquisitions
Due Diligence
Business Development
Licensing
Venture Capital
Investment Banking
M&A experience
Emerging Markets
Private Equity
IPO
Financial Modeling
Biotechnology

Education

  • Uo

    MBA

    University of Rochester - Simon Business School

  • Uo

    MS

    University of Rochester School of Medicine and Dentistry

  • Uo

    MS

    University of Rochester School of Medicine and Dentistry

  • Uo

    BA

    University of Rochester

Lists including Jeff

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Investments

Kenai Therapeutics

Series A

Total Funding: $82M

Atavistik Bio

Series A

Total Funding: $100M

Work Experience

Tortugas Neuroscience

2025

  • Board Member

    2025

Topo Therapeutics

2024

  • Board Member

    2024

NT
NILO Therapeutics

2024

  • Board Member

    2024

KT
Kenai Therapeutics

2024

  • Board Member

    2024

TC
The Column Group

2021

  • Partner

    2024

  • Venture Partner

    2021 - 2023

RT
Remix Therapeutics

2023

  • Board Member

    2023

A
AviadoBio

2023

  • Chair

    2023

JB
Judo Bio

2022

  • Executive Chair

    2022

K
Kallyope

2022

  • Board Member

    2022

AB
Atavistik Bio

2021

  • Board Member

    2021

  • Interim CEO

    2022 - 2023

All information is sourced from public domain and might be inaccurate.

|

By continuing, you're agreeing to our Terms and Privacy Policy.

|

Learn more About The Network.